Logos Global Management LP I Teos Therapeutics, Inc. Transaction History

Logos Global Management LP

  • $756 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$30.86 - $44.2 $3.09 Million - $4.42 Million
-100,000 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$21.59 - $33.95 $4.32 Million - $6.79 Million
-200,000 Reduced 66.67%
100,000 $3.38 Million
Q3 2020

Nov 16, 2020
BUY
$17.57 - $32.92 $5.27 Million - $9.88 Million
300,000 New
300,000 $7.4 Million

Others Institutions Holding ITOS

# of Institutions
166
Shares Held
36.6M
Call Options Held
1.95M
Put Options Held
374K
View Full List

About iTeos Therapeutics, Inc.

ITOS Quotes by TradingView
  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $297M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email